Whim Syndrome
📧 Sign up to get email alerts when something new happens for Whim Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: Efficacy and Safety Study of Mavorixafor in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome [Phase 3]
Phase 3 trial evaluating the efficacy and safety of mavorixafor in WHIM syndrome. The study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: A Dose Determination and Safety Study of X4P-001 (Mavorixafor) in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome [Phase 2]
A Phase 2 dose-determination and safety study of X4P-001 (mavorixafor) in WHIM syndrome has completed, with results posted in 2024 describin…
-
CLINICAL_TRIALS trial_result · 2012-06-15Clinical Trial Update: AMD 3100 for Treatment of Myelokathexis [Phase 1]
A Phase 1 trial of AMD 3100 (plerixafor) for neutropenia in WHIM syndrome (myelokathexis); results were posted in 2012.